These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 26178815)

  • 1. Sumatriptan Iontophoretic Transdermal System Reduces Treatment-Emergent Nausea and Is Effective in Patients With and Without Nausea at Baseline - Results From a Randomized Controlled Trial.
    Bigal ME; Lipton RB; Newman LC; Pierce MW; Silberstein SD
    Headache; 2015 Sep; 55(8):1124-32. PubMed ID: 26178815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal sumatriptan for acute treatment of migraineurs with baseline nausea.
    Schulman EA
    Headache; 2012 Feb; 52(2):204-12. PubMed ID: 22229837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Phase I, Open-Label, Single-Dose Safety, Pharmacokinetic, and Tolerability Study of the Sumatriptan Iontophoretic Transdermal System in Adolescent Migraine Patients.
    Gutman D; Hellriegel E; Aycardi E; Bigal ME; Kunta J; Chitra R; Kansagra S; Kidron OS; Knebel H; Linder S; Ma Y; Pierce M; Winner PK; Spiegelstein O
    Headache; 2016 Sep; 56(8):1300-9. PubMed ID: 27474357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sumatriptan iontophoretic transdermal system: a review of its use in patients with acute migraine.
    Garnock-Jones KP
    Drugs; 2013 Sep; 73(13):1483-90. PubMed ID: 23912626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sumatriptan transdermal system can be correctly assembled and applied during migraine attacks.
    Meadows KP; Pierce M; O'Neill C; Foster S; Jennings C
    Headache; 2014 May; 54(5):850-60. PubMed ID: 24708392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A sumatriptan iontophoretic transdermal system for the acute treatment of migraine.
    Goldstein J; Smith TR; Pugach N; Griesser J; Sebree T; Pierce M
    Headache; 2012 Oct; 52(9):1402-10. PubMed ID: 22694484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twelve-month tolerability and efficacy study of NP101, the sumatriptan iontophoretic transdermal system.
    Smith TR; Goldstein J; Singer R; Pugach N; Silberstein S; Pierce MW
    Headache; 2012 Apr; 52(4):612-24. PubMed ID: 22352764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of rizatriptan and other triptans on the nausea symptom of migraine: a post hoc analysis.
    Lipton RB; Pascual J; Goadsby PJ; Massiou H; McCarroll KA; Vandormael K; Jiang K; Lines CR
    Headache; 2001 Sep; 41(8):754-63. PubMed ID: 11576198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sumatriptan-naproxen for acute treatment of migraine: a randomized trial.
    Brandes JL; Kudrow D; Stark SR; O'Carroll CP; Adelman JU; O'Donnell FJ; Alexander WJ; Spruill SE; Barrett PS; Lener SE
    JAMA; 2007 Apr; 297(13):1443-54. PubMed ID: 17405970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
    Ishkanian G; Blumenthal H; Webster CJ; Richardson MS; Ames M
    Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral sumatriptan for migraine in children and adolescents: a randomized, multicenter, placebo-controlled, parallel group study.
    Fujita M; Sato K; Nishioka H; Sakai F
    Cephalalgia; 2014 Apr; 34(5):365-75. PubMed ID: 24163282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study.
    Winner P; Rothner AD; Wooten JD; Webster C; Ames M
    Headache; 2006 Feb; 46(2):212-22. PubMed ID: 16492230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.
    Derosier F; Sheftell F; Silberstein S; Cady R; Ruoff G; Krishen A; Peykamian M
    Headache; 2012 Apr; 52(4):530-43. PubMed ID: 22103635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of DFN-11 (sumatriptan injection, 3 mg) in adults with episodic migraine: a multicenter, randomized, double-blind, placebo-controlled study.
    Landy S; Munjal S; Brand-Schieber E; Rapoport AM
    J Headache Pain; 2018 Aug; 19(1):69. PubMed ID: 30112726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AVP-825 (Sumatriptan Nasal Powder) Reduces Nausea Compared to Sumatriptan Tablets: Results of the COMPASS Randomized Clinical Trial.
    Lipton RB; McGinley JS; Shulman KJ; Silberstein SD; Wirth RJ; Buse DC
    Headache; 2018 Feb; 58(2):229-242. PubMed ID: 29034453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innovative delivery systems for migraine: the clinical utility of a transdermal patch for the acute treatment of migraine.
    Rapoport AM; Freitag F; Pearlman SH
    CNS Drugs; 2010 Nov; 24(11):929-40. PubMed ID: 20932065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sumatriptan iontophoretic transdermal system for the acute treatment of migraine.
    Vikelis M; Mitsikostas DD; Rapoport AM
    Pain Manag; 2014 Mar; 4(2):123-8. PubMed ID: 24641436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sumatriptan nasal spray: a dose-ranging study in the acute treatment of migraine.
    Peikert A; Becker WJ; Ashford EA; Dahlof C; Hassani H; Salonen RJ
    Eur J Neurol; 1999 Jan; 6(1):43-9. PubMed ID: 10209349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.
    Wendt J; Cady R; Singer R; Peters K; Webster C; Kori S; Byrd S
    Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral sumatriptan is effective and well tolerated for the acute treatment of migraine: results of a multicenter study.
    Sargent J; Kirchner JR; Davis R; Kirkhart B
    Neurology; 1995 Aug; 45(8 Suppl 7):S10-4. PubMed ID: 7644079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.